Project Grant R44GM156258

Award Date 9/25/24
Completion Date 8/31/26
Dollars Obligated $987K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
BRECKNRDG HLS, MO 63114, USA
Similar Awards
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) is funding the development of a Spotting-Free Nano-Oscillator Array (SFNOA) technology by Biosensing Instrument Inc. The SFNOA system aims to enable high-throughput, label-free quantification of ligand binding kinetics to transmembrane proteins in their native states. The $349,566 award, effective from April 2, 2025 to March 31, 2026,...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training Program (CFDA 93.859) provides $295,561 to Biosensing Instrument Inc. to develop a commercial prototype of their Plasmonic Scattering Microscopy (PSM) technology. The PSM system aims to enable high-throughput, label-free quantification of membrane protein binding kinetics on single cells in their native cellular microenvironment. This represents a...
The National Institute of General Medical Sciences (NIGMS) awarded a $297,664 Phase I Small Business Technology Transfer (STTR) grant to Blotting Innovations, LLC under the Biomedical Research and Research Training program (CFDA 93.859). The purpose of this project is to develop two innovative products for western blotting, a widely used protein analysis technique in biomedical research: A "Gelbrane" cassette that combines a polyacrylamide gel and transfer membrane in a single pre-cast...
This Project Grant award, provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), is funding the development of novel signal amplification technologies by Molecular Instruments, Inc. to enable automated, ultrasensitive, and multiplex imaging of RNA and protein expression in biological samples. The $1,099,625 award supports the engineering of two key capabilities: 1) a chromogenic signal amplification...
This $306,872 Project Grant awarded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) supports the development of a commercial prototype for Fluid Discovery, Inc.'s "Universal Platform for Ultrahigh-Throughput Biocatalyst Evolution with Micro-Mass Spectrometry." This transformative screening platform combines scalable hardware, label-free mass spectrometry, and advanced computational techniques to...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) under CFDA program 93.859 Biomedical Research and Research Training provides $350,000 to Fluidispec LLC to develop a new microfluidic/nanofluidic sample preparation platform. The goal is to improve single-cell and low-input proteomics analysis by enabling efficient extraction of proteins from cells, removal of contaminants, and improved protein denaturation. This platform is expected to enhance...
This Project Grant award from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships) provides $305,000.00 to Primary Bioscience, Inc. to develop an ultra-sensitive biosensor capable of protein analysis at the single-molecule level. The biosensor consists of a nanopatterned chip with a proprietary material that binds and immobilizes molecular targets, which are then detected using surface-enhanced Raman spectroscopy (SERS). This technology aims to enable...
This $769,749 Project Grant from the National Institutes of Health's National Institute of General Medical Sciences will support the development of Fluorescence Enhanced Photothermal Infrared Spectroscopy (FE-PTIR) technology by Photothermal Spectroscopy Corp. The FE-PTIR technique aims to provide simultaneous fluorescence microscopy and sub-micron infrared spectroscopy to map the distribution of fluorescently labeled biomolecules within cells and tissues while also analyzing their chemical...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) provides $267,323 to Uforce Biotechnology, LLC to develop a quantum sensing device to accelerate the drug development process and increase its success rate. The key objectives are to integrate a commercial optically pumped magnetometer with an array of piezo disks for force generation, and to resolve multiple samples located on a standard...
This $402,500 Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to develop a novel approach that combines modular fluorophores and correlative super-resolution microscopy to investigate the structure, dynamics, and interactome of biomolecular condensates in bacteria. The project, being conducted at New York University, will apply this "opto-proteomic toolbox" to understand the role of...

This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $986,651 to Auragent Bioscience LLC (doing business as Brightest Bio) to develop an ultrabright fluorescent reagent called a Plasmonic Fluor (PF). The PF technology is designed to significantly enhance the detection sensitivity of fluorescent Western blot assays, enabling more precise protein concentration measurements and analysis of post-translationally modified protein variants. The project also includes the creation of a low-cost prototype reader that can outperform existing fluorescent Western blot readers when combined with the PF technology. The goal is to provide a cost-effective platform for ultrasensitive fluorescent immunoblot assays that can advance biological and biomedical research capabilities. The project period runs from September 2024 to August 2026.

Generated 7/1/25, 3:56 AM